Strong Adjusted EBITDA Performance
Fourth-quarter net income was $169 million, with adjusted EBITDA at $594 million, showing strong phosphate prices, solid potash performance, and excellent business performance in Brazil.
Operational Improvements in Potash
Belle Plaine potash mine delivered a 100% operating rate and record production in 2024. Electrical issues were resolved, and full milling and hoisting capacity is now achieved.
Strategic Progress in Capital Reallocation
Mosaic made several strategic deals including the sale of Patos de Minas site in Brazil and concluded the Ma’aden transaction, valuing their investment at $1.5 billion and providing a $522 million gain.
Optimistic Agriculture Market Outlook
Improved agriculture markets with expected strong demand for phosphate and potash due to high global crop prices and tight supply.
Cost Reduction Initiatives
Mosaic is confident in achieving $150 million in cost reduction targets, with significant progress already made, especially in SG&A and operational efficiencies.
Mosaic Biosciences Growth
Mosaic Biosciences doubled revenues and acreage in 2024, with expectations for similar growth in 2025.